OpenAI ousted Sam Altman as its chief last week after the board said it no longer had confidence in his ability to lead the company.Finance, news, Openai, Sam Altman, AIRead More

You might also be interested in reading Novo’s Wegovy beats Lilly’s Zepbound in real-world study for heart diseases.